Carriage Services, Inc. (CSV)
NYSE: CSV · Real-Time Price · USD
45.22
+0.30 (0.67%)
Aug 1, 2025, 4:00 PM - Market closed
Oncternal Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Oncternal Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $50.5, which forecasts a 11.68% increase in the stock price over the next year. The lowest target is $50 and the highest is $51.
Price Target: $50.50 (+11.68%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Oncternal Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $50 | Buy | Maintains | $50 | +10.57% | Jul 30, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $48 → $51 | Strong Buy | Reiterates | $48 → $51 | +12.78% | May 2, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $50 | Buy | Maintains | $50 | +10.57% | May 1, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $50 | Buy | Maintains | $50 | +10.57% | Feb 28, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $50 | Buy | Maintains | $50 | +10.57% | Feb 10, 2025 |
Financial Forecast
Revenue This Year
412.11M
from 404.20M
Increased by 1.96%
Revenue Next Year
424.18M
from 412.11M
Increased by 2.93%
EPS This Year
3.25
from 2.10
Increased by 54.87%
EPS Next Year
3.38
from 3.25
Increased by 4.04%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 432.3M | 452.6M |
| Avg | 412.1M | 424.2M |
| Low | 396.9M | 403.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 7.0% | 9.8% |
| Avg | 2.0% | 2.9% |
| Low | -1.8% | -2.1% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 3.49 | 3.68 |
| Avg | 3.25 | 3.38 |
| Low | 3.06 | 3.08 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 66.0% | 13.0% |
| Avg | 54.9% | 4.0% |
| Low | 45.6% | -5.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.